Novartis Japan VP Ninomiya Becomes New President April 1
This article was originally published in PharmAsia News
Executive Summary
Novartis Japan Managing Director and Head of Human Resources and Communication Hiroko Ishikawa has been named the new president of Novartis Holdings Japan, while Vice President and Pharmaceutical Department Head Yoshiyasu Ninomiya will take over her former position April 1.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.